Aspen Neuroscience Appoints Jeff Boerneke as General Counsel and Secretary
Experienced biotech legal executive strengthens leadership team as Aspen advances clinical development and prepares for Phase 3 growth SAN DIEGO, June 11, 2026 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage regenerative medicine biotechnology company developing personalized,...
View original →